Prospectus

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maison Solutions, Dada, Future FinTech, and AlloVir and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, February 17, 2024

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • Additional information about each case can be found at the link provided.
  • Specifically, AlloVir said it was discontinuing the posoleucel Phase 3 studies after pre-planned analyses concluded they wouldn’t meet their primary endpoints.
  • For more information on the AlloVir class action go to: https://bespc.com/cases/ALVR

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, and Boeing and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, February 17, 2024

The Company sells and delivers a range of products in the food, alcohol, consumer health, pet care, and ready-made meals categories, in addition to others.

Key Points: 
  • The Company sells and delivers a range of products in the food, alcohol, consumer health, pet care, and ready-made meals categories, in addition to others.
  • The Company offers its services through a mobile application and website, while also providing software-as-a-service solutions to retailers.
  • Throughout the Class Period, Defendants continued to assure investors that Boeing was laser-focused on safety and quality.
  • These false and misleading statements caused Boeing stock to trade at artificially inflated prices during the Class Period.

Arisz Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Retrieved on: 
Friday, February 16, 2024

The Extension is the first of up to nine (9) one-month extensions permitted under the February 5, 2024 amendment to the Amended and Restated Certificate of Incorporation of Arisz Acquisition Corp.

Key Points: 
  • The Extension is the first of up to nine (9) one-month extensions permitted under the February 5, 2024 amendment to the Amended and Restated Certificate of Incorporation of Arisz Acquisition Corp.
  • The Extension provides Arisz with additional time to complete its proposed business combination with Finfront Holding Company (“BitFuFu”).
  • Statements that are not historical facts, including statements about the pending transactions described above, and the parties’ perspectives and expectations, are forward-looking statements.
  • Stockholders will also be able to obtain a copy of the Registration Statement and proxy statement without charge from Arisz.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Maison Solutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MSS

Retrieved on: 
Friday, February 16, 2024

WHAT TO DO NEXT: To join the Maison Solutions class action, go to https://rosenlegal.com/submit-form/?case_id=21393 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Maison Solutions class action, go to https://rosenlegal.com/submit-form/?case_id=21393 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Ohmyhome Announces Closing of Upsized $4.8 Million Public Offering of Ordinary Shares

Retrieved on: 
Friday, February 16, 2024

Singapore, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore, today announced the closing of its upsized public offering of 3,555,555 ordinary shares at a public offering price of $1.35 per ordinary share.

Key Points: 
  • Singapore, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore, today announced the closing of its upsized public offering of 3,555,555 ordinary shares at a public offering price of $1.35 per ordinary share.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, were approximately $4.8 million.
  • Maxim Group LLC acted as sole placement agent in connection with this offering.
  • The offering was made only by means of a prospectus which is a part of the Registration Statement.

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Friday, February 16, 2024

The aggregate gross proceeds to Larimar from this offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $172.5 million.

Key Points: 
  • The aggregate gross proceeds to Larimar from this offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $172.5 million.
  • Leerink Partners, Citigroup and Guggenheim Securities acted as joint bookrunning managers for the offering.
  • LifeSci Capital acted as lead manager for the offering.
  • The shares were offered pursuant to a shelf registration statement on Form S-3 (File No.

Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Friday, February 16, 2024

Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares, at a price to the public of $20.00 per share.

Key Points: 
  • Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares, at a price to the public of $20.00 per share.
  • The gross proceeds to Immunome from the offering, before deducting underwriting discounts and commissions and offering expenses, are $230.0 million.
  • All of the shares in the offering were sold by Immunome.
  • J.P. Morgan, TD Cowen, Leerink Partners and Guggenheim Securities acted as joint book-running managers for the offering.

Azitra, Inc. Announces Closing of Public Offering

Retrieved on: 
Friday, February 16, 2024

Azitra, Inc. (NYSE American: AZTR) (the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public offering of 16,667,000 shares of common stock, at a public offering price of $0.30 per share.

Key Points: 
  • Azitra, Inc. (NYSE American: AZTR) (the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public offering of 16,667,000 shares of common stock, at a public offering price of $0.30 per share.
  • Total gross proceeds from the offering, before deducting underwriting discounts and other offering expenses, were approximately $5 million.
  • In addition, Azitra has granted the underwriters a 45-day option to purchase up to an additional 2,500,000 shares of common stock to cover over-allotments at the public offering price, less the underwriting discount.
  • A prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov .

ToughBuilt Industries Announces Closing of $3.5 Million Public Offering

Retrieved on: 
Friday, February 16, 2024

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from the offering were approximately $3.5 million, before deducting the placement agent’s fees and other offering expenses payable by ToughBuilt.
  • The Company intends to use the net proceeds from this offering for general corporate purposes, including working capital.
  • The offering was made only by means of a prospectus, which is part of the effective registration statement.

Unusual Machines Announces Closing of $5,000,000 Initial Public Offering

Retrieved on: 
Friday, February 16, 2024

SAN JUAN, Puerto Rico, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (“Unusual Machines” or the “Company”), an emerging leader in first-person view (FPV) drone technology, announced today the closing of its initial public offering (the “Offering”) of 1,250,000 shares of common stock at a public offering price of $4.00 per share.

Key Points: 
  • SAN JUAN, Puerto Rico, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (“Unusual Machines” or the “Company”), an emerging leader in first-person view (FPV) drone technology, announced today the closing of its initial public offering (the “Offering”) of 1,250,000 shares of common stock at a public offering price of $4.00 per share.
  • The Company expects to receive aggregate gross proceeds of $5.0 million from the Offering, before deducting underwriting discounts and other related expenses.
  • The Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 common shares at the public offering price (the “Over-allotment Option”), less underwriting discounts.
  • acted as U.S. counsel to the Company and Sichenzia Ross Ference Carmel LLP acted as U.S. counsel to the Underwriters in connection with the Offering.